Literature DB >> 31552129

(New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples.

Jeffrey D Jenks1, Birgit Spiess2, Dieter Buchheidt2, Martin Hoenigl1,3.   

Abstract

PURPOSE OF REVIEW: The incidence of invasive aspergillosis has increased substantially over the past few decades, accompanied by a change in susceptibility patterns of Aspergillus fumigatus with increasing resistance observed against triazole antifungals, including voriconazole and isavuconazole, the most commonly used antifungal agents for the disease. Culture-based methods for determining triazole resistance are still the gold standard but are time consuming and lack sensitivity. We sought to provide an update on non-culture-based methods for detecting resistance patterns to Aspergillus. RECENT
FINDINGS: New molecular-based approaches for detecting triazole resistance to Aspergillus, real-time polymerase chain reaction (PCR) to detect mutations to the Cyp51A protein, have been developed which are able to detect most triazole-resistant A. fumigatus strains in patients with invasive aspergillosis.
SUMMARY: Over the last few years, a number of non-culture-based methods for molecular detection of Aspergillus triazole resistance have been developed that may overcome some of the limitations of culture. These molecular methods are therefore of high epidemiological and clinical relevance, mainly in immunocompromised patients with hematological malignancies, where culture has particularly limited sensitivity. These assays are now able to detect most triazole-resistant Aspergillus fumigatus strains. Given that resistance rates vary, clinical utility for these assays still depends on regional resistance patterns.

Entities:  

Keywords:  Cyp51A gene; Invasive aspergillosis; Isavuconazole; Triazoles; Voriconazole

Year:  2019        PMID: 31552129      PMCID: PMC6759225          DOI: 10.1007/s12281-019-00342-w

Source DB:  PubMed          Journal:  Curr Fungal Infect Rep        ISSN: 1936-3761


  61 in total

1.  Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  Detection of Aspergillus fumigatus and a mutation that confers reduced susceptibility to itraconazole and posaconazole by real-time PCR and pyrosequencing.

Authors:  Jason P Trama; Eli Mordechai; Martin E Adelson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Multiple-triazole-resistant aspergillosis.

Authors:  Paul E Verweij; Emilia Mellado; Willem J G Melchers
Journal:  N Engl J Med       Date:  2007-04-05       Impact factor: 91.245

4.  Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens.

Authors:  Jan W M van der Linden; Eveline Snelders; Jan P Arends; Simon M Daenen; Willem J G Melchers; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

5.  MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole.

Authors:  Carine Marinach; Alexandre Alanio; Martine Palous; Stéphanie Kwasek; Arnaud Fekkar; Jean-Yves Brossas; Sophie Brun; Georges Snounou; Christophe Hennequin; Dominique Sanglard; Annick Datry; Jean-Louis Golmard; Dominique Mazier
Journal:  Proteomics       Date:  2009-10       Impact factor: 3.984

6.  E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.

Authors:  Ana Espinel-Ingroff; A Rezusta
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration.

Authors:  Jeff Fuller; Adam Schofield; Safeer Jiwa; Crystal Sand; Brad Jansen; Robert Rennie
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

8.  Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.

Authors:  Estrella Martín-Mazuelos; Javier Pemán; Anastasio Valverde; Mónica Chaves; M Carmen Serrano; Emilia Cantón
Journal:  J Antimicrob Chemother       Date:  2003-08-13       Impact factor: 5.790

9.  In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.

Authors:  M A Pfaller; S A Messer; L Boyken; R J Hollis; D J Diekema
Journal:  Diagn Microbiol Infect Dis       Date:  2003-04       Impact factor: 2.803

10.  Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.

Authors:  Ricardo Araujo; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

View more
  9 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

2.  Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus.

Authors:  Alexandre Mendonça; Joana Carvalho-Pereira; Ricardo Franco-Duarte; Paula Sampaio
Journal:  Mol Diagn Ther       Date:  2022-06-16       Impact factor: 4.476

3.  A 9-Year Experience of Aspergillus Infections from Isfahan, Iran.

Authors:  Mostafa Chadeganipour; Rasoul Mohammadi
Journal:  Infect Drug Resist       Date:  2020-07-14       Impact factor: 4.003

Review 4.  Detecting Azole-Antifungal Resistance in Aspergillus fumigatus by Pyrosequencing.

Authors:  Mireille H van der Torre; Lilyann Novak-Frazer; Riina Rautemaa-Richardson
Journal:  J Fungi (Basel)       Date:  2020-01-10

Review 5.  The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update.

Authors:  Jeffrey D Jenks; Marisa H Miceli; Juergen Prattes; Toine Mercier; Martin Hoenigl
Journal:  Curr Fungal Infect Rep       Date:  2020-12-04

Review 6.  Fungal infections diagnosis - Past, present and future.

Authors:  Alexandre Mendonça; Helena Santos; Ricardo Franco-Duarte; Paula Sampaio
Journal:  Res Microbiol       Date:  2021-12-01       Impact factor: 3.946

Review 7.  Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection.

Authors:  Jeffrey D Jenks; Stephen A Rawlings; Carol Garcia-Vidal; Philipp Koehler; Toine Mercier; Juergen Prattes; Cornelia Lass-Flörl; M Teresa Martin-Gomez; Dieter Buchheidt; Livio Pagano; Jean-Pierre Gangneux; Frank L van de Veerdonk; Mihai G Netea; Agostinho Carvalho; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2019-12-16

8.  Protective Efficacy of Lectin-Fc(IgG) Fusion Proteins In Vitro and in a Pulmonary Aspergillosis In Vivo Model.

Authors:  Claudia Rodriguez-de la Noval; Susana Ruiz Mendoza; Diego de Souza Gonçalves; Marina da Silva Ferreira; Leandro Honorato; José Mauro Peralta; Leonardo Nimrichter; Allan J Guimarães
Journal:  J Fungi (Basel)       Date:  2020-10-27

9.  Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.

Authors:  Jeffrey D Jenks; Jean-Pierre Gangneux; Ilan S Schwartz; Ana Alastruey-Izquierdo; Katrien Lagrou; George R Thompson Iii; Cornelia Lass-Flörl; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2020-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.